Speaker illustration

Ms Parisa Danaietash

Idorsia Pharmaceuticals, Allschwil (Switzerland)

Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension

Event: ESC Congress 2019

Topic: Treatment

Session: Drug treatment in hypertension - New insights

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb